Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population

被引:101
作者
Varbo, Anette [1 ,2 ,3 ,4 ]
Nordestgaard, Barge G. [2 ,3 ,4 ,5 ]
机构
[1] Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark
[3] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Copenhagen, Denmark
[4] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark
[5] Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark
关键词
DENSITY-LIPOPROTEIN CHOLESTEROL; GENETICALLY HYPERLIPIDEMIC RABBITS; EUROPEAN ATHEROSCLEROSIS SOCIETY; JOINT CONSENSUS STATEMENT; ALL-CAUSE MORTALITY; LIPID PROFILE; LDL CHOLESTEROL; CARDIOVASCULAR-DISEASE; CLINICAL-CHEMISTRY; METABOLIC SYNDROME;
D O I
10.1002/ana.25432
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective High remnant cholesterol concentrations are associated with high risk of ischemic heart disease, but whether this is also the case for ischemic stroke is unknown. We tested the hypothesis that high remnant cholesterol concentrations are associated with increased risk of ischemic stroke in the general population. Methods A total of 102,964 individuals from the Copenhagen General Population Study with information on remnant cholesterol at baseline in 2003-2015 were included in a prospective, observational association study. Individuals were followed for up to 14 years, during which time 2,488 were diagnosed with an ischemic stroke. Hazard ratios were estimated using Cox proportional hazard regression models. Results were independently confirmed in 9,548 individuals enrolled in the Copenhagen City Heart Study in 1991-1994; 983 ischemic strokes developed during up to 26 years of follow-up. Results Step-wise higher remnant cholesterol concentrations were associated with step-wise higher ischemic stroke risk in the Copenhagen General Population Study, with multivariable adjusted hazard ratios up to 1.99 (95%confidence interval: 1.49-2.67) for individuals with remnant cholesterol concentrations >= 1.5 mmol/l (58 mg/dl), compared to individuals with remnant cholesterol <0.5 mmol/l (19 mg/dl). Results were similar in the Copenhagen City Heart Study. Cumulative incidence of ischemic stroke at age 80 in the Copenhagen General Population Study ranged from 7.3% for individuals with remnant cholesterol <0.5 mmol/l (19 mg/dl) to 11.5% for individuals with remnant cholesterol >= 1.5 mmol/l (58 mg/dl). Interpretation Individuals with high remnant cholesterol concentrations had higher risk of ischemic stroke. These results indicate that randomized clinical trials with remnant cholesterol lowering in individuals with high concentrations, with the aim of preventing ischemic strokes, are needed. Ann Neurol 2019;85:550-559
引用
收藏
页码:550 / 559
页数:10
相关论文
共 44 条
  • [1] Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
    Alberti, K. G. M. M.
    Eckel, Robert H.
    Grundy, Scott M.
    Zimmet, Paul Z.
    Cleeman, James I.
    Donato, Karen A.
    Fruchart, Jean-Charles
    James, W. Philip T.
    Loria, Catherine M.
    Smith, Sidney C., Jr.
    [J]. CIRCULATION, 2009, 120 (16) : 1640 - 1645
  • [2] Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
    Amarenco, Pierre
    Labreuche, Julien
    [J]. LANCET NEUROLOGY, 2009, 8 (05) : 453 - 463
  • [3] Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
    Baigent, C.
    Blackwell, L.
    Emberson, J.
    Holland, L. E.
    Reith, C.
    Bhala, N.
    Peto, R.
    Barnes, E. H.
    Keech, A.
    Simes, J.
    Collins, R.
    [J]. LANCET, 2010, 376 (9753) : 1670 - 1681
  • [4] Relationship of Familial Hypercholesterolemia and High Low-Density Lipoprotein Cholesterol to Ischemic Stroke: Copenhagen General Population Study
    Beheshti, Sabina
    Madsen, Christian M.
    Varbo, Anette
    Benn, Marianne
    Nordestgaard, Borge G.
    [J]. CIRCULATION, 2018, 138 (06) : 578 - 589
  • [5] Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
    Bhatt, Deepak L.
    Steg, P. Gabriel
    Miller, Michael
    Brinton, Eliot A.
    Jacobson, Terry A.
    Ketchum, Steven B.
    Doyle, Ralph T., Jr.
    Juliano, Rebecca A.
    Jiao, Lixia
    Granowitz, Craig
    Tardif, Jean-Claude
    Ballantyne, Christie M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (01) : 11 - 22
  • [6] Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe
    Bots, ML
    Elwood, PC
    Nikitin, Y
    Salonen, JT
    de Concalves, AF
    Inzitari, D
    Sivenius, J
    Benetou, V
    Tuomilehto, J
    Koudstaal, PJ
    Grobbee, DE
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2002, 56 : I19 - I24
  • [7] Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619
  • [8] Freiberg JJ, 2008, JAMA-J AM MED ASSOC, V300, P2142, DOI [10.1001/jama.2008.621, 10.1002/ana.22384]
  • [9] Grundy SM, 2019, J AM COLL CARDIOL, V73, pE285, DOI 10.1016/j.jacc.2018.11.003
  • [10] Low-Grade Inflammation in the Association between Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis: A Study of More Than 115000 Individuals from the General Population
    Hansen, Signe E. J.
    Madsen, Christian M.
    Varbo, Anette
    Nordestgaard, Borge G.
    [J]. CLINICAL CHEMISTRY, 2019, 65 (02) : 321 - 332